These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2140204)
1. Antithrombotic effects of recombinant hirudin in experimental angioplasty and intravascular thrombolysis. Kaiser B; Simon A; Markwardt F Thromb Haemost; 1990 Feb; 63(1):44-7. PubMed ID: 2140204 [TBL] [Abstract][Full Text] [Related]
2. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis. Kaiser B; Fareed J Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005 [TBL] [Abstract][Full Text] [Related]
3. Reocclusion after thrombolysis: a problem solved by hirudin? Rübsamen K; Eschenfelder V Blood Coagul Fibrinolysis; 1991 Feb; 2(1):97-100. PubMed ID: 1773004 [TBL] [Abstract][Full Text] [Related]
4. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits. Agnelli G; Pascucci C; Cosmi B; Nenci GG Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121 [TBL] [Abstract][Full Text] [Related]
5. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728. Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524 [TBL] [Abstract][Full Text] [Related]
6. The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost. Peters RF; Lees CM; Mitchell KA; Tweed MF; Talbot MD; Wallis RB Thromb Haemost; 1991 Mar; 65(3):268-74. PubMed ID: 1710836 [TBL] [Abstract][Full Text] [Related]
7. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model. Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787 [TBL] [Abstract][Full Text] [Related]
13. Anticoagulant and antithrombotic actions of recombinant hirudin. Kaiser B Semin Thromb Hemost; 1991 Apr; 17(2):130-6. PubMed ID: 1837615 [No Abstract] [Full Text] [Related]
14. Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin. Rübsamen K; Hornberger W Thromb Haemost; 1996 Jul; 76(1):105-10. PubMed ID: 8819261 [TBL] [Abstract][Full Text] [Related]
15. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin. Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009 [TBL] [Abstract][Full Text] [Related]
16. The effects of recombinant desulphatohirudin on arterial thrombosis in rats. Talbot MD; Ambler J; Butler KD; Lees CM; Mitchell KA; Peters RF; Tweed MF; Wallis RB Haemostasis; 1991; 21 Suppl 1():73-9. PubMed ID: 1654294 [TBL] [Abstract][Full Text] [Related]
17. [Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis]. Weber MA; Lorenz RL; Schramm W; Theisen K Z Kardiol; 1986; 75 Suppl 5():107-11. PubMed ID: 2950673 [TBL] [Abstract][Full Text] [Related]
18. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]. Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470 [TBL] [Abstract][Full Text] [Related]
19. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group. Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats. Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]